In Brief: Spine-Tech
This article was originally published in The Gray Sheet
Spine-Tech: Firm plans controlled worldwide market launch in the fourth quarter of 1997 of its BAK/Proximity implant for use in spinal fusion procedures to treat symptomatic degenerative disc disease following recent marketing clearance from FDA, the firm states. The device, which is intended for use in patients with a small anatomy, differs from the firm's flagship BAK implant in that it features "greater porosity," concave sides, and allows for closer placement between the vertebrae of two implants, one BAK and one BAK/Proximity...
You may also be interested in...
Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump. The Indian company continues to perform well internationally and grow overall.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.